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Background
The family under investigation consists of parents and
two daughters, one being the proband. The mother and
the proband have elongated facial features. The father
and second daughter appear normal. The older daughter
presented for elective tonsillectomy aged 8 years. She
had severe masseter spasm after suxamethonium. The
rest of the procedure was carried out under total intra-
venous anaesthesia. No blood gas analysis could be
done, but a creatine kinase next day was significantly
elevated (2934). This led to study of both parents. There
was no family history of malignant hyperthermia but an
undefined myopathy was suspected in mother and
daughter. Both mother and father were diagnosed malig-
nant hyperthermia (MH) susceptible by in vitro contrac-
ture test (IVCT). This prompted a DNA analysis for
variants associated with MH.
Materials and methods
Standard histochemistry, biochemistry and electron
microscopy were carried out on muscle tissue from the
mother. DNA from all four family members was analysed
by targeted exon capture and next generation sequencing
using the Ion Torrent platform. B-lymphoblastoid cells
were generated from all family members and assayed for
abnormal calcium release.
Results
The mother and both daughters carry a premature stop
codon in ryanodine receptor subtype 1 (RYR1) as well
an uncharacterized RYR1 variant inherited from the
father. The mother also carries a second uncharacterized
RYR1 variant, not inherited by either daughter. Muscle
histology showed two cox-negative fibres suggestive of a
mitochondrial disorder but not definitive. Calcium
release assays using B-lymphoblastoid cells suggest a
hypersensitive RyR1 channel in all four family members.
Conclusions
The RYR1 variants identified cannot be definitively asso-
ciated with susceptibility to MH, although the functional
assays in B-lymphoblastoid cells suggest a hypersensitive
channel. It is possible that the undefined myopathy is asso-
ciated with another gene and the MH susceptible result by
IVCT is unrelated to this condition. Further analysis of the
family is required for a definitive diagnosis.
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